These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones. Dierselhuis EF, Goulding KA, Stevens M, Jutte PC. Cochrane Database Syst Rev; 2019 Mar 07; 3(3):CD010778. PubMed ID: 30845364 [Abstract] [Full Text] [Related]
6. Intralesional curettage and cementation for low-grade chondrosarcoma of long bones: retrospective study and literature review. Mermerkaya MU, Bekmez S, Karaaslan F, Danisman M, Kosemehmetoglu K, Gedikoglu G, Ayvaz M, Tokgozoglu AM. World J Surg Oncol; 2014 Nov 10; 12():336. PubMed ID: 25382793 [Abstract] [Full Text] [Related]
9. Outcome of conservative and surgical treatment of enchondromas and atypical cartilaginous tumors of the long bones: retrospective analysis of 228 patients. Omlor GW, Lohnherr V, Lange J, Gantz S, Mechtersheimer G, Merle C, Raiss P, Fellenberg J, Lehner B. BMC Musculoskelet Disord; 2019 Mar 28; 20(1):134. PubMed ID: 30922289 [Abstract] [Full Text] [Related]
10. Long-term results of intralesional curettage and cryosurgery for treatment of low-grade chondrosarcoma. Meftah M, Schult P, Henshaw RM. J Bone Joint Surg Am; 2013 Aug 07; 95(15):1358-64. PubMed ID: 23925739 [Abstract] [Full Text] [Related]
12. Outcomes of curettage and anhydrous alcohol adjuvant for low-grade chondrosarcoma of long bone. Kim W, Han I, Kim EJ, Kang S, Kim HS. Surg Oncol; 2015 Jun 07; 24(2):89-94. PubMed ID: 25912950 [Abstract] [Full Text] [Related]
14. Intralesional curettage, with phenol and cement as adjuvants, for low-grade intramedullary chondrosarcoma of the long bones. Di Giorgio L, Touloupakis G, Vitullo F, Sodano L, Mastantuono M, Villani C. Acta Orthop Belg; 2011 Oct 07; 77(5):666-9. PubMed ID: 22187844 [Abstract] [Full Text] [Related]
15. Surgical management of grade I chondrosarcoma of the long bones. Gunay C, Atalar H, Hapa O, Basarir K, Yildiz Y, Saglik Y. Acta Orthop Belg; 2013 Jun 07; 79(3):331-7. PubMed ID: 23926738 [Abstract] [Full Text] [Related]
16. [Clinical observation of surgical management for recurrent giant cell tumor of bone]. Kong Q, Yang J, Xing R, Tu C, Zhou Y, Zhang H, Duan H. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan 07; 27(1):36-40. PubMed ID: 23427489 [Abstract] [Full Text] [Related]
17. Intralesional curettage of central low-grade chondrosarcoma: A midterm follow-up study. Chen YC, Wu PK, Chen CF, Chen WM. J Chin Med Assoc; 2017 Mar 07; 80(3):178-182. PubMed ID: 27889461 [Abstract] [Full Text] [Related]
18. Oncologic impact of the curettage of grade 2 central chondrosarcoma of the extremity. Cho WH, Song WS, Jeon DG, Kong CB, Koh JS, Kim JI, Lee SY. Ann Surg Oncol; 2011 Dec 07; 18(13):3755-61. PubMed ID: 21611858 [Abstract] [Full Text] [Related]
19. Effect of adjuvant therapies on recurrence in aneurysmal bone cysts. Keçeci B, Küçük L, Isayev A, Sabah D. Acta Orthop Traumatol Turc; 2014 Dec 07; 48(5):500-6. PubMed ID: 25429574 [Abstract] [Full Text] [Related]
20. Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones. van der Heijden L, van de Sande MA, Dijkstra PD. Acta Orthop; 2012 Aug 07; 83(4):401-5. PubMed ID: 22880716 [Abstract] [Full Text] [Related] Page: [Next] [New Search]